Article
No appeal process: HHS refusal to cover AMD therapy sparks suit
Washington, DC-Several organizations have joined three patients with age-related macular degeneration (AMD) in a lawsuit filed against the Department of Health and Human Services in an effort to appeal the department's ruling that Medicare would not cover ocular photodynamic therapy (PDT) with verteporfin.
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Related Videos
Related Content
